Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in Arch Pathol Lab Med Retrieve available abstracts of 25 articles: HTML format Text format

Single Articles

December 2018
1. LAMBROS L, Uguen A
   NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?
   Arch Pathol Lab Med. 2018;142:1451-1452.
   PubMed     Text format    
   
   
   November 2018
2. TROSCHEL FM, Gottumukkala RV, DiCorpo D, Mario J, et al
   Feasibility of Perioperative Micro-Computed Tomography of Human Lung Cancer Specimens: A Pilot Study.
   Arch Pathol Lab Med. 2018 Nov 20. doi: 10.5858/arpa.2018-0249.
   PubMed     Text format     Abstract available
   
   
   October 2018
3. THUNNISSEN E
   How to Validate Predictive Immunohistochemistry Testing in Pathology?: A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non-Small Cell Lung Cancer.
   Arch Pathol Lab Med. 2018 Oct 11. doi: 10.5858/arpa.2018-0410.
   PubMed     Text format    
   
   
   August 2018
4. AKALIN A, Ergin A, Remiszewski S, Mu X, et al
   Resolving Interobserver Discrepancies in Lung Cancer Diagnoses by Spectral Histopathology.
   Arch Pathol Lab Med. 2018 Aug 24. doi: 10.5858/arpa.2017-0476.
   PubMed     Text format     Abstract available
   
   
   
5. BORCZUK AC
   Uncommon Types of Lung Carcinoma With Mixed Histology: Sarcomatoid Carcinoma, Adenosquamous Carcinoma, and Mucoepidermoid Carcinoma.
   Arch Pathol Lab Med. 2018;142:914-921.
   PubMed     Text format     Abstract available
   
   
   July 2018
6. BORCZUK AC
   Keeping Up With Testing Guidelines in Lung Cancer.
   Arch Pathol Lab Med. 2018;142:783-784.
   PubMed     Text format    
   
   
   June 2018
7. LUK PP, Selinger CI, Mahar A, Cooper WA, et al
   Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization.
   Arch Pathol Lab Med. 2018 Jun 14. doi: 10.5858/arpa.2017-0502.
   PubMed     Text format     Abstract available
   
   
   April 2018
8. SAXENA A
   Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients with Targetable Mutations Following Disease Progression.
   Arch Pathol Lab Med. 2018 Apr 12. doi: 10.5858/arpa.2018-0111.
   PubMed     Text format    
   
   
   
9. PLANCHARD D, Johnson BE
   BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer.
   Arch Pathol Lab Med. 2018 Apr 12. doi: 10.5858/arpa.2018-0088.
   PubMed     Text format    
   
   
   
10. HALMOS B
    Molecular Testing in Lung Cancer: Where to Draw the Line?
    Arch Pathol Lab Med. 2018 Apr 6. doi: 10.5858/arpa.2018-0060.
    PubMed     Text format    
    
    
    
11. ALTORKI NK
    Molecular Testing for Early Lung Cancer.
    Arch Pathol Lab Med. 2018 Apr 6. doi: 10.5858/arpa.2018-0087.
    PubMed     Text format    
    
    
    March 2018
12. AISNER DL
    The Revised College of American Pathologists/International Association for the Study of Lung Cancer Guidelines/Association for Molecular Pathology: A Step Forward for Molecular Cytopathology.
    Arch Pathol Lab Med. 2018 Mar 29. doi: 10.5858/arpa.2018-0081.
    PubMed     Text format    
    
    
    
13. JAIN D, Roy-Chowdhuri S
    Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review.
    Arch Pathol Lab Med. 2018 Mar 16. doi: 10.5858/arpa.2017-0444.
    PubMed     Text format     Abstract available
    
    
    
14. LOZANO MD, Echeveste JI, Abengozar M, Mejias LD, et al
    Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.
    Arch Pathol Lab Med. 2018;142:291-298.
    PubMed     Text format     Abstract available
    
    
    February 2018
15. DEL C MONROIG-BOSQUE P, Driver B, Morales-Rosado JA, Deavers M, et al
    Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.
    Arch Pathol Lab Med. 2018 Feb 12. doi: 10.5858/arpa.2017-0516.
    PubMed     Text format     Abstract available
    
    
    January 2018
16. DOXTADER EE, Cheng YW, Zhang Y
    Molecular Testing of Non-Small Cell Lung Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Fine-Needle Aspiration.
    Arch Pathol Lab Med. 2018 Jan 26. doi: 10.5858/arpa.2017-0184.
    PubMed     Text format     Abstract available
    
    
    
17. LINDEMAN NI, Cagle PT, Aisner DL, Arcila ME, et al
    Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and
    Arch Pathol Lab Med. 2018 Jan 22. doi: 10.5858/arpa.2017-0388.
    PubMed     Text format     Abstract available
    
    
    
18. WALTS AE, Marchevsky AM
    Current Evidence Does Not Warrant Frozen Section Evaluation for the Presence of Tumor Spread Through Alveolar Spaces.
    Arch Pathol Lab Med. 2018;142:59-63.
    PubMed     Text format     Abstract available
    
    
    
19. HUSAIN AN, Colby TV, Ordonez NG, Allen TC, et al
    Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
    Arch Pathol Lab Med. 2018;142:89-108.
    PubMed     Text format     Abstract available
    
    
    December 2017
20. MEHRAD M, Roy S, Bittar HT, Dacic S, et al
    Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations.
    Arch Pathol Lab Med. 2017 Dec 8. doi: 10.5858/arpa.2017-0046.
    PubMed     Text format     Abstract available
    
    
    November 2017
21. DRIVER BR, Miller RA, Miller T, Deavers M, et al
    Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
    Arch Pathol Lab Med. 2017;141:1529-1532.
    PubMed     Text format     Abstract available
    
    
    September 2017
22. WOO JS, Reddy OL, Koo M, Xiong Y, et al
    Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural Neoplasms.
    Arch Pathol Lab Med. 2017;141:1195-1213.
    PubMed     Text format     Abstract available
    
    
    August 2017
23. PENG Y, Butt YM, Chen B, Zhang X, et al
    Update on Immunohistochemical Analysis in Breast Lesions.
    Arch Pathol Lab Med. 2017;141:1033-1051.
    PubMed     Text format     Abstract available
    
    
    July 2017
24. WANG X, Gao Y, Wang B, Zhang Z, et al
    Analytic and Clinical Validation of an Ultrasensitive, Quantitative Polymerase Chain Reaction Assay for EGFR Mutation Analysis With Circulating Tumor DNA.
    Arch Pathol Lab Med. 2017;141:978-984.
    PubMed     Text format     Abstract available
    
    
    June 2017
25. JAIN D, Allen TC, Aisner DL, Beasley MB, et al
    Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.
    Arch Pathol Lab Med. 2017 Jun 22. doi: 10.5858/arpa.2017-0114.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: